Lesaffre et Compagnie
Records under this name other than the patents Lesaffre et Compagnie holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 76 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,736,925 | Probiotics strains for treating and/or preventing diarrhea Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,750,774 | Strain for the treatment and/or prevention of chronic inflammatory diseases Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,837,030 | Yeast propagation simultaneous with saccharification Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,802,182 | Bread-Making Improver Lapsed on the fee record Ended Aug 12, 2026 · High confidence | Lapsed on the fee record | Ended Aug 12, 2026 | High confidence |
| US 9,725,691 | Yeast strains capable of metabolizing xylose and resistant to inhibitors, method for obtaining same and use thereof Lapsed on the fee record Ended Aug 8, 2025 · From the USPTO record | Lapsed on the fee record | Ended Aug 8, 2025 | From the USPTO record |
| US 9,717,751 | Chitin or derivatives thereof for the prevention and/or treatment of parasitoses Lapsed on the fee record Ended Aug 1, 2025 · From the USPTO record | Lapsed on the fee record | Ended Aug 1, 2025 | From the USPTO record |
| US 8,313,785 | Liquid Yeast Compositions Lapsed on the fee record Ended Nov 20, 2024 · High confidence | Lapsed on the fee record | Ended Nov 20, 2024 | High confidence |
| US 9,176,131 | Method for diagnosing and treating Crohn's disease Lapsed on the fee record Ended Nov 3, 2023 · From the USPTO record | Lapsed on the fee record | Ended Nov 3, 2023 | From the USPTO record |
| US 7,309,599 | Aerobic Fermentation Method Term ended Term ended Oct 14, 2022 · High confidence | Term ended | Term ended Oct 14, 2022 | High confidence |
| US 7,459,159 | Yeast cell walls for the treatment or prevention of hyperglycemia or for the stabilization of glycemia Lapsed on the fee record Ended Dec 2, 2020 · From the USPTO record | Lapsed on the fee record | Ended Dec 2, 2020 | From the USPTO record |